Y.-T. Wu, M. Noltemeyer, A. de Meijere
H), 5.33–5.35 and 5.42–5.43 (m, 2 H, 4Ј-H), 6.86 (s, 1 H, 4-H), 3 d. Chromatography on aluminum oxide (act. II, 40 g) eluting with
FULL PAPER
7.08–7.23 (m, 4 H, 5,6,7,8-H) ppm. 13C NMR (62.9 MHz, CDCl3,
plus DEPT): δ = 23.5 (+, CH3), 27.5, 27.7 (–, C-1,2), 89.9, 92.6
(Cquat, CϵC), 121.0, 126.9, 133.7, 134.7 (Cquat, C-3,9,10,3Ј), 121.7
(–, C-4Ј), 126.3, 126.6, 127.4, 127.6, 133.1 (+, C-4,5,6,7,8) ppm.
pentane/Et2O (from 1:0 to 3:1) gave 231 mg (51%) of 8ah-iPr and
9ah-iPr [Rf = 0.64 (pentane/Et2O, 3:1); ratio 1.1:1] as a pale-yellow
oil. IR (film): ν = 2960 cm–1 (C–H), 1706 (C=O), 1609, 1465, 1399,
˜
1269, 736. 1H NMR (250 MHz, CDCl3): δ = 0.41, 0.46 (d, 3J =
3
MS (70 eV): m/z (%) = 194 (100) [M+], 178 (40), 165 (10), 152 (12), 6.8 Hz, 3 H, iPr-H), 1.03, 1.04 (d, J = 6.8 Hz, 3 H, iPr-H), 2.00–
128 (14), 115 (12). C15H14 (194.3): calcd. C 92.74, H 7.26; found
C 92.84, H 7.02.
2.57 (m, 5 H, 2,7-H and iPr-H), 2.33, 2.56 (s, 3 H, CH3), 2.78–2.92
(m, 3 H) and 3.12–3.18 (m, 1 H) [total 4 H, 6,8-H], 3.30–3.32, 3.39–
3.41 (m, 1 H, 3-H of 8ah-iPr and 1-H of 9ah-iPr), 6.95, 7.20 (s, 1 H,
5-H) ppm. 13C NMR (62.9 MHz, CDCl3, plus DEPT): δ = 14.8,
14.9, 18.1, 18.3 (+, iPr-C), 21.8, 22.1 (+, CH3), 25.2, 25.3 (–, C-7),
28.7, 29.1 (+, iPr-C), 30.5, 30.6, 31.5, 32.8 (–, C-6,8), 37.9, 38.0
(–, C-2), 42.8, 43.2 (+, C-3 of 8ah-iPr and C-1 of 9ah-iPr), 125.5,
131.6 (+, C-5), 132.7, 132.9, 133.1, 136.5, 138.1, 139.7, 144.5, 151.5,
154.3 × 2 (Cquat, Ar-C), 207.3, 207.8 (Cquat, CO) ppm. MS (70 eV):
m/z (%) = 228 (40) [M+], 186 (25), 185 (100) [M+ – C3H7]. C16H20O
(228.3): calcd. C 84.16, H 8.83; found C 83.96, H 8.68.
(4aR)-4a-Methyl-7-(3Ј-methylbut-3Ј-en-1Ј-ynyl)-1,2,3,4,4a,5,6,8a-oc-
tahydronaphthalene (2gh): Preparation according to GP1. To a solu-
tion of (4aR)-4a-methyl-3,4,4a,5,6,7,8,8a-octahydronaphthalen-2-
yl trifluoromethanesulfonate (5g) (4.47 g, 15.0 mmol) in DMF
(40 mL) was added PPh3 (50 mg), CuI (50 mg), LiCl (50 mg),
PdCl2(PPh3)2 (60 mg), NEt3 (1.52 g, 15.0 mmol) and 2-methylbut-
1-en-3-yne (6h) (4.00 mL, 42.9 mmol), and the mixture was heated
at 50 °C for 12 h. The reaction mixture was diluted with 50 mL of
pentane/Et2O (1:1) and washed with water (200 mL). The aqueous
phase was extracted with pentane/Et2O (1:1; 4 × 50 mL). The com-
bined organic phases were washed with water (30 mL) and hydro-
chloric acid (1 n, 30 mL). The solution was dried with MgSO4. Af-
ter filtration and evaporation of the solvents under reduced pres-
sure, the residue was subjected to chromatography on silica gel
(100 g). Elution with pentane gave 2.74 g (85%) of 2gh [Rf — 0.63
3-Isopropyl-2,3,4,5,6,7,8,9-octahydrotrinden-1-one (8aa-iPr): Prepa-
ration according to GP2. To a solution of complex 1-iPr (723 mg,
2.00 mmol) in pyridine (40 mL) was added di(1-cyclopentenyl)eth-
yne (2aa) (633 mg, 4.00 mmol), and the mixture was stirred at
80 °C for 3 d. Chromatography on aluminum oxide (act. II, 40 g)
eluting with pentane/Et2O (from 1:0 to 3:1) gave 382 mg (75%) of
8aa-iPr [Rf = 0.63 (pentane/Et2O, 3:1)] as a colorless solid, m.p.
(pentane)] as a colorless oil. IR (film): ν = 2922 cm–1 (C–H), 2855,
˜
2188 (CϵC), 1671 (C=C), 1608, 1446, 1373, 891. 1H NMR
121–122 °C. IR (KBr): ν = 2956 cm–1 (C–H), 1695 (C=O), 1588,
˜
1
3
(250 MHz, CDCl3): δ = 0.80 (s, 3 H, CH3), 1.02–1.57 (9 H) and 1448, 1281, 1126. H NMR (250 MHz, CDCl3): δ = 0.43 (d, J =
1.68–2.05 (4 H) (m, total 13 H, 1,2,3,4,5,6,8a-H), 1.89 (s, 3 H, 6.8 Hz, 3 H, iPr-H), 0.98 (d, 3J = 6.8 Hz, 3 H, iPr-H), 1.94–2.22
CH3), 5.16–5.18 and 5.22–5.24 (m, 2 H, 4Ј-H), 5.98–6.01 (m, 1 H, (m, 4 H, 5,8-H), 2.23–2.48 (m, 3 H, iPr-H, 2-H), 2.69 (t, 3J =
8-H) ppm. 13C NMR (62.9 MHz, CDCl3, plus DEPT): δ = 16.3 (+,
7.6 Hz, 2 H), 2.76 (t, J = 7.9 Hz, 2 H), 2.87 (t, J = 7.7 Hz, 2 H),
3
3
3
CH3), 22.1, 26.6, 28.4, 34.0, 40.9, 42.6 (–, C-1,2,3,4,5,6), 23.6 (+,
and 3.11 (t, J = 7.4 Hz, 2 H) [total 8 H, 4,6,7,9-H], 3.20–3.35 (m,
CH3), 31.5 (Cquat, C-4a), 39.9 (+, C-8a), 87.9, 89.9 (Cquat, CϵC), 1 H, 3-H) ppm. 13C NMR (62.9 MHz, CDCl3, plus DEPT): δ =
119.7, 127.0 (Cquat, C-7,3Ј), 120.8 (+, C-8), 133.7 (–, C-4Ј) ppm.
14.6, 21.6 (+, iPr-C), 25.0 × 2 (–, C-5,8), 28.5 (+, iPr-C), 30.0, 30.4,
MS (70 eV): m/z (%) = 214 (100) [M+], 199 (59) [M+ – CH3], 185 30.6, 31.2 (–, C-4,6,7,9), 37.4 (–, C-2), 43.2 (+, C-3), 131.4, 138.2,
(10), 171 (23), 157 (34), 143 (30), 131 (20), 118 (96), 95 (29), 91
(38), 81 (50), 77 (21), 67 (39), 55 (29), 53 (14), 41 (36). C16H22
(214.4): calcd. C 89.65, H 10.35; found C 89.99, H 10.97.
139.6, 140.6, 147.0, 151.7 (Cquat, Ar-C), 206.6 (Cquat, C-1) ppm. MS
(70 eV): m/z (%) = 254 (26) [M+], 211 (100) [M+ – C3H7]. C18H22O
(254.4): calcd. C 84.99, H 8.72; found C 84.74, H 8.50.
3-Isopropyl-4,7-dimethylindan-1-one (8hh-iPr): Preparation accord-
ing to GP2. To a solution of complex 1-iPr (723 mg, 2.00 mmol) in
pyridine (40 mL) was added 2,5-dimethylhexa-1,5-dien-3-yne (2hh)
(531 mg, 5.00 mmol), and the mixture was stirred at 80 °C for 3 d.
Chromatography on aluminum oxide (act. II, 40 g) eluting with
pentane/Et2O (from 1:0 to 3:1) gave 282 mg (70%) of 8hh-iPr [Rf
3-Isopropyl-2,3,4,5,6,7,8,9,10,11-decahydrocyclopenta[l]phenan-
thren-1-one (8bb-iPr): Preparation according to GP2. To a solution
of complex 1-iPr (723 mg, 2.00 mmol) in pyridine (40 mL) was
added di(1-cyclohexenyl)ethyne (2bb) (745 mg, 4.00 mmol), and the
mixture was stirred at 80 °C for 4 d. Chromatography on aluminum
oxide (act. II, 40 g) eluting with pentane/Et2O (from 1:0 to 3:1)
gave 382 mg (68%) of 8bb-iPr [Rf = 0.73 (pentane/Et2O, 3:1)] as a
= 0.65 (pentane/Et O, 3:1)] as a colorless oil. IR (film): ν =
˜
2
2984 cm–1 (C–H), 1705 (C=O), 1581, 1495, 1248, 821. 1H NMR colorless solid, m.p. 148–149 °C. IR (KBr): ν = 2931 cm–1 (C–H),
˜
3
(250 MHz, CDCl3): δ = 0.37 (d, J = 6.8 Hz, 3 H, iPr-H), 1.02 (d,
1692 (C=C), 1571, 1546, 1278, 1124. 1H NMR (250 MHz, CDCl3):
3J = 6.8 Hz, 3 H, iPr-H), 2.23–2.37 (m, 1 H, iPr-H), 2.31 (s, 3 H, δ = 0.41 (d, 3J = 6.8 Hz, 3 H, iPr-H), 1.04 (d, 3J = 6.8 Hz, 3 H,
3
CH3), 2.44–2.47 (m, 2 H, 2-H), 2.53 (s, 3 H, CH3), 3.35 (qui, J = iPr-H), 1.50–2.10 (m, 8 H, 5,6,9,10-H), 2.22–2.82 (m, 9 H, iPr-H,
3
3
3
7.9, J = 7.9, J = 7.9 Hz, 1 H, 3-H), 6.94 (d, J = 7.5 Hz, 1 H, 5- 4,7,8,11-H), 3.08–3.23 (m, 2 H, 2-H), 3.23–3.35 (m, 1 H, 3-H) ppm.
H), 7.16 (d, 3J = 7.5 Hz, 1 H, 6-H) ppm. 13C NMR (62.9 MHz, 13C NMR (62.9 MHz, CDCl3, plus DEPT): δ = 14.6, 22.0 (+, iPr-
CDCl3, plus DEPT): δ = 14.7 (+, iPr-C), 17.7, 17.8 (+, CH3), 21.6 C), 21.8, 22.1, 22.6, 22.8, 25.9, 26.3, 26.4, 27.2 (–, C-
(+, iPr-C), 29.0 (+, iPr-C), 38.2 (–, C-2), 42.5 (+, C-3,4), 129.2,
135.2 (+, C-5,6), 132.2, 134.3, 135.3, 156.6 (Cquat, C-3a,4,7,7a),
207.9 (Cquat, C-1,2,5,6) ppm. MS (70 eV): m/z (%) = 202 (48) [M+],
160 (41), 159 (100) [M+ – C3H7], 129 (10), 116 (12), 115 (16), 91
(10). C14H18O (202.3): calcd. C 83.12, H 8.97; found C 82.80,
H 8.69.
4,5,6,7,8,9,10,11), 28.5 (+, iPr-C), 38.4 (–, C-2), 42.0 (+, C-3),
131.4, 131.4, 134.1, 134.7, 142.3, 154.7 (Cquat, Ar-C), 207.8 (Cquat
C-1) ppm. MS (70 eV): m/z (%) = 282 (54) [M+], 239 (100) [M+
C3H7]. C20H26O (282.4): calcd. C 85.06, H 9.28; found C 84.84,
H 9.34.
,
–
17-Isopropyl-12-methyl-6,7,16,17-tetrahydrocyclopenta[a]phenan-
3-Isopropyl-4-methyl-3,6,7,8-tetrahydro-2H-as-indacen-1-one (8ah- thren-15-one (14eh-iPr) and 15-Isopropyl-12-methyl-6,7,15,16-tetra-
iPr) and 1-Isopropyl-4-methyl-1,6,7,8-tetrahydro-2H-as-indacen-3-
one (9ah-iPr): Preparation according to GP2. To a solution of com-
plex 1-iPr (723 mg, 2.00 mmol) in pyridine (40 mL) was added 4-
hydrocyclopenta[a]phenanthren-17-one (15eh-iPr). Variant A: Prepa-
ration according to GP2. To a solution of complex 1-iPr (723 mg,
2.00 mmol) in pyridine (40 mL) was added 3-(3Ј-methylbut-3Ј-en-
(1Ј-cyclopentenyl)-2-methylbut-1-en-3-yne (2ah) (651 mg; 1Ј-ynyl)-1,2-dihydronaphthalene (2eh) (583 mg 3.00 mmol) and the
4.43 mmol; 90% purity) and the mixture was stirred at 80 °C for mixture was stirred at 80 °C for 3 d. After dilution with Et2O,
2808
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2005, 2802–2810